IGC Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
IGC Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
- IGC Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 76M shares, a 40% increase year-over-year.
- IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2016 was 25.7M shares, a 56.6% increase from 2015.
- IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2015 was 16.4M shares, a 11.1% increase from 2014.
- IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2014 was 14.8M shares, a 79.8% increase from 2013.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)